Effects of Epinephrine, Detomidine, and Butorphanol on Assessments of Insulin Sensitivity in Mares

Document Type

Article

Publication Date

2-1-2020

Abstract

© 2019 Elsevier Inc. Sympathoadrenal stimulation may perturb results of endocrine tests performed on fractious horses. Sedation may be beneficial; however, perturbation of results may preclude useful information. Four experiments were designed to 1) determine the effects of epinephrine on insulin response to glucose (IR2G), 2) assess the effects of detomidine (DET), alone or combined with butorphanol (DET/BUT), on IR2G and glucose response to insulin (GR2I), and 3) assess the effects of BUT alone on IR2G. In Experiment 1, mares were administered saline or epinephrine (5 μg/kg BW) immediately before infusion of glucose (100 mg/kg BW). Glucose stimulated (P <.05) insulin release in controls at 5 minutes that persisted through 30 minutes; insulin was suppressed (P <.05) by epinephrine from 5 to 15 minutes, rising gradually through 30 minutes. Experiments 2 (IR2G) and 3 (GR2I) were conducted as triplicated 3 × 3 Latin squares with the following treatments: saline (SAL), DET, and DET/BUT (all administered at.01 mg/kg BW). Glucose stimulated (P <.05) insulin release that persisted through 30 minutes in SAL mares; DET and DET/BUT severely suppressed (P <.0001) the IR2G. Sedation did not affect resting glucose and had inconsistent effects on the GR2I when mares were treated with 50 mIU/kg BW recombinant human insulin. Butorphanol had no effect on IR2G. In conclusion, adrenergic agonists severely suppress the IR2G and cannot be used for sedation for this test. The use of DET did not alter the GR2I, and therefore may be useful for conducting this test in fractious horses.

Publication Source (Journal or Book title)

Journal of Equine Veterinary Science

This document is currently not available here.

Share

COinS